BioCentury
ARTICLE | Politics & Policy

Sklamberg departing FDA

February 28, 2017 12:12 AM UTC

Deputy Commissioner for Global Regulatory Operations and Policy Howard Sklamberg will leave the agency on March 3 "to pursue new opportunities.” News of his departure came in an agency-wide email from Acting Commissioner Stephen Ostroff on Friday.

According to an FDA statement, Sklamberg had informed former FDA Commissioner Robert Califf in September 2016 that he planned to leave the agency early this year...